treatment considerations for patients with metastatic urothelial carcinoma
Published 6 years ago • 197 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
3:37
optimal treatment strategies for patients with metastatic urothelial carcinoma
-
1:08
future treatment approaches for patients with bladder cancer
-
1:54
targeted therapy effective for patients with advanced bladder cancer and specific gene mutations
-
20:21
targeted therapy for the treatment of advanced metastatic urothelial cancer youtube
-
1:23
recent advances in the use of targeted therapies for metastatic urothelial carcinoma
-
1:11
dr. mayer fishman on new a treatment for patients with metastatic chemo-refractory urothelial cancer
-
1:56
analyzing frontline options for patients with bladder cancer
-
1:04
choosing second-line therapy for patients with urothelial carcinoma
-
40:12
improving patient outcomes in urothelial carcinoma with novel antibody–drug conjugates
-
1:12
dr. vogelzang discusses mpdl3280a in patients with metastatic urothelial bladder cancer
-
0:42
targeted therapies in metastatic urothelial carcinoma
-
2:04
areas of unmet need in metastatic urothelial carcinoma
-
1:03:24
bladder cancer: understanding immune-, targeted-, and antibody-based models for patient care
-
0:16
imvigor 210 results in metastatic urothelial carcinoma
-
14:16
new emerging treatment options and targeted therapies for bladder cancer
-
1:10
updated efficacy results for avelumab in metastatic urothelial carcinoma
-
4:06
targeting agent enfortumab vedotin a novel treatment for patients with advanced urothelial cancer
-
31:39
the evolving role of antibody-drug conjugates in the treatment of urothelial carcinoma
-
0:50
enfortumab vedotin appears well-tolerated and active in advanced bladder cancers